Vernalis Systems: Vernalis hit by fresh U.S. setback for cough and cold drug

LONDON Reuters Shares in Vernalis fell 5.3 percent on Monday as the British biotech company backed by fund manager Neil Woodford and his previous employer Invesco announced a fresh setback for a key new drug in the United States.